CooperVision’s Brilliant Futures™ Myopia Management Program Now Available in Canada

CooperVision announced the Canadian launch of the Brilliant Futures™ Myopia Management Program featuring the innovative MiSight® 1 day contact lens.

The Brilliant Futures™ Myopia Management Program seeks to create a new standard of care for children with myopia. It provides inclusive practice, child and parent support to create the optimal environment for compliance, satisfaction, clinical outcomes and long-term loyalty, all via a comprehensive management program featuring MiSight® 1 day daily disposable contact lenses. MiSight® 1 day is the first soft contact lens clinically proven to slow the progression of myopia (or nearsightedness) in age appropriate children.

The Brilliant Futures™ Myopia Management Program features:

  • Ongoing education and support on the MiSightPro™ resource portal.
  • Support from a dedicated Myopia Management Specialist to answer any questions regarding myopia management or the Brilliant Futures program.
  • Free product shipping, including directly to patients’ homes
  • Hassle-free return policy
  • A Brilliant Futures™ resource portal to help patients stay compliant with their lens-wearing schedule and engaged with their program of care, providing convenient access to myopia management information, lens handling instructions and videos, and more.

The MiSight® 1 day lens is already being successfully worn by thousands of myopic children in many parts of the world, including right here in Canada, the United Kingdom, Spain and Australia, where age ranges for initial fitting may vary. It has been recognized as one of the most innovative developments in myopia management by the likes of the British Contact Lens Association and international industry media.

Click HERE for the full press release.

Featured Posts

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read more

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read more

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read more

Winners of the 30th SILMO d’Or

And here are the winners!

Read more

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read More

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read More

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read More

Winners of the 30th SILMO d’Or

And here are the winners!

Read More

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read more

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read more

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read more

Winners of the 30th SILMO d’Or

And here are the winners!

Read more

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read more

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read more

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read more

Winners of the 30th SILMO d’Or

And here are the winners!

Read more